Plunkett Research Online: Versartis Inc

VERSARTIS INC (VSAR:NAS) Company Profile, Corporate Revenues, Growth, Market Size, Analysis, Business Forecasts, Market Share, Metrics, SWOT

Versartis Inc operates in the biotechnology and pharmaceutical industry. The company is developing novel, long-acting medicines to transform treatment for patients with endocrine disorders. The company's lead candidate, somavaratan (VRS-317), is a novel, long-acting form of recombinant human growth .....



Versartis Inc
Ticker: VSAR
Exchange: NAS
Parent Company:
Year Established:
Employees:
Fiscal Year Ends in

Phone: 650 963-8580
Fax:
Address: 1020 Marsh Road
Menlo Park, CA 94025 United States

Types Of Business
Industry Ranks

Industry NAICS code:

Pharmaceuticals, Biopharmaceuticals, Generics and Drug Manufacturing
ContactsDescription
Jay ShepardCEO/Director/President/CFO
Srinivas AkkarajuChairman of the Board/Director
See More
Versartis Inc operates in the biotechnology and pharmaceutical industry. The company is developing novel, long-acting medicines to transform treatment for patients with endocrine disorders. The company's lead candidate, somavaratan (VRS-317), is a novel, long-acting form of recombinant human growth .....See More See More

Auditor: PricewaterhouseCoopers LLP
Legal Advisor:
$USD, In whole numbers,
except marked * or %
201720162015201420132012
Financials
    Revenue
    Cost of Revenue
    Gross Margin %
    R&D Expense
    Operating Income
    Operating Margin %
    SGA Expense
    Net Income
    Earnings Per Share
    Dividends
    Book Value Per Share
    Operating Cash Flow
    Capital Expenditure
    Free Cash Flow
Profitability
    EBITDA
    Return on Assets %
    Return on Equity %
    Net Margin %
    Assets Turnover
    Financial Leverage
Brands, Divisions and AffiliatesTop Salaries
NameTitleSalary (US$)Bonus (US$)
Other ThoughtsCorporate Culture

Apparent Female Officers or Directors: